Navigation Links
Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs
Date:4/29/2008

PITTSBURGH, April 29 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced the appointment of Michael J. Monroe as senior vice president - Global Public Affairs and as a member of the company's senior leadership team. In this role, Monroe is responsible globally for executive, financial and employee communications; corporate branding/marketing; corporate media relations; Internet management, sponsorships and event planning. In addition, he oversees the strategic coordination of communications for the company, working closely with Mylan's operating and support units.

"Mike is a talented and experienced senior executive," said Mylan's Vice Chairman and CEO Robert J. Coury. "His broad-based background and understanding of international public affairs will serve Mylan well as we strengthen our strategic global communications activities. We are fortunate to have added someone of Mike's caliber to Mylan's senior leadership team."

Monroe served previously as executive vice president - Public Affairs and chief communications officer for KeyCorp, one of the nation's largest financial services companies. During his 30 year career, he also completed assignments of increasing responsibility at CIGNA Corporation, The American Express Company and AT&T Long Lines Division.

Monroe earned a bachelor's degree from Rutgers University, graduating magna cum laude. He also holds a master's degree in journalism from Columbia University.

He is a member of The Phi Beta Kappa Society, The Public Relations Seminar and The Wisemen. He has chaired the Public Affairs Council of The Financial Services Roundtable and is the former chair of The Conference Board's Communications Council.

Mylan Inc., with operations in more than
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Announces Final FDA Approval for Trandolapril Tablets
2. Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
3. Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter
4. Mylan Announces Appointment of Jagdish Dore as CEO and Managing Director of Matrix Laboratories
5. Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET
6. Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th
7. Mylan Restores Availability of Generic Levothyroxine in Florida
8. Mylan Schedules Financial Results Conference Call and Live Webcast for the Quarter and Nine Months Ended Dec. 31, 2007
9. Mylan Declares Quarterly Preferred Stock Dividend
10. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
11. Mylan Announces Final FDA Approval for Cetirizine Hydrochloride Tablets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., Craig Moskowitz, a four...of Medicine, is choosing to go into internal medic... North Brunswick, NJ (PRWEB) December 1...cores on the US medical licensing examinations, Cr...ss University School of Medicine--knew he could go...
(Date:12/1/2009)..., Recent Reviews In Major... One Of The Most Promising New Developments For Th...tive Functioning Difficulties. Some Of The Most Re...(PRWEB) December 1, 2009 -- Review written by: Lee...sorders , Volume 13, No. 3 November 2009. A nice s...
(Date:12/1/2009)..., Anthony M. Marlon, MD w.... (“Stemedica”) Board of Directors at ..., (PRWEB) December 1, 2009...edica Cell Technologies , Inc. (“Stemedica&r...ovember 20th Board Meeting. Roger J. Howe, PhD, Ex...
(Date:12/1/2009)..., All Federal and Georgia... hearing aid benefits. This new benefit is part of...drugs (MAPD) private fee for service (PFFS) Option... Healthcare and Kaiser Permanente. Atlanta Hearing... in Dunwoody, GA Lake Oconee / Greensboro, GA and ...
(Date:12/1/2009)..., , EAGAN, Minn., Dec. 1 ...proach to health care for Blue Cross and Blue Shie...ers today, becoming the first Minnesotans - and th...o Online Care Anywhere(SM). Online Care Anywhere a... work simply by logging onto a computer or picking...
Breaking Medicine News(10 mins):Health News:Trending Against the Norm: How One Top Scoring Ross University Medical Student is Choosing to Make a Difference in Internal Medicine 2Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 2Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 3Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 2Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 3Health News:Retired Fed. & GA State Employees Get New Hearing Healthcare Benefit, Jan. 2010 4Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3
...chers at the University of Pennsylvania School of ...ity have identified for the first time a specific ...timulating factor 1, Csf1, that has a direct effec...lated by the pituitary gland to supply testosteron...
... March 6 Alexza Pharmaceuticals, Inc. (Nasdaq: ...s for its fiscal year ended December 31, 2008, on ...e U.S. financial markets. The Company will host a...f the call will be available for two weeks followi...
... Supporters of the Glenda Dawson Donate Life - T...l at the Texas State Capitol on March 26, between ...onor registration process and getting them signed ... be in front of the Capitol Grill at the Texas St...
... The Crossings, the Texas Hill Country spa retrea...Day for each day booked. From March 8 until Apri...hree healthy gourmet meals, gracious and comfortab...finity pool, whirlpool, cold plunge, Watsu pool, s...
...h., March 6 Versus Technology,Inc. ("Versus" or t...venues of,$1,613,000 for the fiscal quarter ended ...$1,426,000 for the same period in 2008. The growt...nues can vary,significantly depending upon the tim...
...Health Care: Pharmacy and Other Services category;...ment worldwide , , FRANKLIN LAKES, N.J., March 6 ...ured the No. 1 position within the Health Care: Ph...d No. 5 in Innovation and No. 10 in People Managem...
Other Medicine News:Health News:Penn vet researchers identify a critical growth factor that stimulates sperm stem cells to thrive 2Health News:Penn vet researchers identify a critical growth factor that stimulates sperm stem cells to thrive 3Health News:Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009 2Health News:Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009 3Health News:Donate Life Day at the Capitol to Increase Awareness for Organ Donation and Registration 2Health News:Donate Life Day at the Capitol to Increase Awareness for Organ Donation and Registration 3Health News:Donate Life Day at the Capitol to Increase Awareness for Organ Donation and Registration 4Health News:A Massage A Day at The Crossings 2Health News:Versus Technology Announces First Quarter Results 2Health News:Versus Technology Announces First Quarter Results 3Health News:Versus Technology Announces First Quarter Results 4Health News:Versus Technology Announces First Quarter Results 5Health News:Versus Technology Announces First Quarter Results 6Health News:Medco Tops Fortune's Lists of 'World's Most Admired' Companies 2Health News:Medco Tops Fortune's Lists of 'World's Most Admired' Companies 3
(Date:11/30/2009)... , CHICAGO, Nov. 30 MedPro I...ultrasound solutions, will showcase leading ultras... Logiq I and Siemens X300 Premium Edition during t...f North America (RSNA) conference, being held in C...ased MedPro Imaging markets ultrasound products an...
(Date:11/30/2009)... , CHICAGO, Nov. 30 Minim...g more costly open surgery, particularly in oncolo...ith a global market for image-guided navigation ex...re embracing the advantages offered by minimally-i...very times, greater patient comfort and faster pat...
(Date:11/30/2009)... , WAYNE, N.J. and CHICAGO, Nov. 30 /PRNewswi...nnual Meeting of the Radiological Society of Nor...s Inc. announced the enrollment of the first patie... evaluate the efficacy and safety of florbetaben (...Amyloid plaques in the brain, which are a patholog...
Breaking Medicine Technology:MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 2Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 3Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 4Philips Showcases Interventional Radiology Solutions to Support Growing Need For Minimally-Invasive Procedures 5Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 1DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 2DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 3DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 4DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 5Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment 51043 1Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment 51043 2Transdel Pharmaceuticals Completes Enrollment in Phase 3 Clinical Study for Novel Topical Pain Treatment 51043 3Breakfast Anyone 3F Lifestyle Foods Launches Two Energizing Snacks Containing Under 200 Calories 51041 1Breakfast Anyone 3F Lifestyle Foods Launches Two Energizing Snacks Containing Under 200 Calories 51041 2
...BRUNSWICK, N.J., May 7 Johnson & Johnson,will pro... on Friday, May 9,at 4:00 p.m. (Eastern Time) to c...ual meeting in Tampa, Fla. Phase 3 clinical data p...te release (IR), a novel centrally acting,oral ana...S., A pre-recorded Webcast, with the lead tapenta...
...-Large Study Shows Benefits Differ from those in A...n to,children who are hospitalized for bacterial m...in reduced hospital stays, according to a large,mu...ding stands in contrast,to previous studies in hos...cally reduced mortality., "Because of the demonst...
Other Medicine Technology:Steroids Provide No Survival Benefit for Children With Bacterial Meningitis 2Steroids Provide No Survival Benefit for Children With Bacterial Meningitis 3
Ultra Thin Sheet
Tanne Corneal Cutting Block
Surgical Markers
Periosteal Elevator
Medicine Products: